# POM (POMDOCTOR Ltd) - SEC EDGAR Financial Statements

> POMDOCTOR Ltd reported ¥399.9M in revenue and a net loss of ¥212.6M for the fiscal year ended December 31, 2025 (up 16.7% year over year), with a 13.1% gross margin and a -29.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/POM
- Markdown: https://convexityos.com/fundamentals/POM.md
- SEC CIK: 0001877971
- Reporting currency: CNY
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:05 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001877971&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | ¥399.9M | +16.7% YoY |
| Operating Income | FY 2025 | -¥118.6M | -29.7% margin |
| Net Income | FY 2025 | -¥212.6M | -53.2% net margin |
| Diluted EPS | FY 2025 | -¥21.96 | Split-adjusted |
| Free Cash Flow | FY 2025 | -¥149.5M | -37.4% FCF margin |
| Cash & ST Investments | Dec 31, 2025 | ¥9.58M | Total debt: ¥55.84M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | ¥399.9M | ¥342.6M | ¥304.9M |
| Cost of Revenue | ¥347.6M | ¥294.9M | ¥266.1M |
| **Gross Profit** | ¥52.28M | ¥47.69M | ¥38.72M |
| Research & Development | ¥12.86M | ¥3.00M | ¥3.37M |
| Selling, General & Admin | ¥155.9M | ¥68.24M | ¥55.99M |
| Total Operating Expenses | ¥170.9M | ¥73.49M | ¥60.97M |
| **Operating Income** | -¥118.6M | -¥25.79M | -¥22.25M |
| **EBITDA** | -¥118.5M | -¥25.66M | -¥22.14M |
| Interest Expense | ¥3.94M | ¥3.63M | ¥3.00M |
| Income Before Tax | -¥130.9M | -¥37.37M | -¥36.95M |
| Income Tax Expense | ¥375 | -- | -- |
| **Net Income** | -¥212.6M | -¥143.4M | -¥145.4M |
| Basic EPS | -¥21.96 | -¥22.72 | -¥23.04 |
| **Diluted EPS** | -¥21.96 | -¥22.72 | -¥23.04 |
| Basic Shares Outstanding | 9.7M | 6.3M | 6.3M |
| Diluted Shares Outstanding | 9.7M | 6.3M | 6.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | ¥9.58M | ¥7.65M |
| **Cash & Short-Term Investments** | ¥9.58M | ¥7.65M |
| Accounts Receivable, Net | ¥18.44M | ¥8.37M |
| Inventory | ¥8.28M | ¥9.17M |
| Other Current Assets | ¥3.56M | ¥2.68M |
| **Total Current Assets** | ¥105.0M | ¥37.50M |
| Property, Plant & Equipment, Net | ¥1.25M | ¥461K |
| Other Non-Current Assets | ¥1.34M | ¥831K |
| **Total Non-Current Assets** | ¥2.59M | ¥8.73M |
| **Total Assets** | ¥107.6M | ¥46.23M |
| Accounts Payable | ¥44.81M | ¥25.32M |
| Short-Term Debt | ¥53.00M | ¥34.96M |
| Other Current Liabilities | -- | ¥2.08M |
| **Total Current Liabilities** | ¥218.2M | ¥179.1M |
| **Total Non-Current Liabilities** | ¥370.7M | ¥366.8M |
| **Total Liabilities** | ¥588.9M | ¥545.9M |
| **Total Debt (incl. Leases)** | ¥55.84M | ¥38.02M |
| Retained Earnings | -¥2.48B | -¥2.26B |
| Accumulated Other Comp. Income | -¥1.75M | -¥5.2K |
| **Total Stockholders' Equity** | -¥454.0M | -¥2.26B |
| Total Equity | -¥481.3M | -¥2.26B |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | ¥9.58M | ¥7.65M |
| **Cash & Short-Term Investments** | ¥9.58M | ¥7.65M |
| Accounts Receivable, Net | ¥18.44M | ¥8.37M |
| Inventory | ¥8.28M | ¥9.17M |
| Other Current Assets | ¥3.56M | ¥2.68M |
| **Total Current Assets** | ¥105.0M | ¥37.50M |
| Property, Plant & Equipment, Net | ¥1.25M | ¥461K |
| Other Non-Current Assets | ¥1.34M | ¥831K |
| **Total Non-Current Assets** | ¥2.59M | ¥8.73M |
| **Total Assets** | ¥107.6M | ¥46.23M |
| Accounts Payable | ¥44.81M | ¥25.32M |
| Short-Term Debt | ¥53.00M | ¥34.96M |
| Other Current Liabilities | -- | ¥2.08M |
| **Total Current Liabilities** | ¥218.2M | ¥179.1M |
| **Total Non-Current Liabilities** | ¥370.7M | ¥366.8M |
| **Total Liabilities** | ¥588.9M | ¥545.9M |
| **Total Debt (incl. Leases)** | ¥55.84M | ¥38.02M |
| Retained Earnings | -¥2.48B | -¥2.26B |
| Accumulated Other Comp. Income | -¥1.75M | -¥5.2K |
| **Total Stockholders' Equity** | -¥454.0M | -¥2.26B |
| Total Equity | -¥481.3M | -¥2.26B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -¥130.9M | -¥37.37M | -¥36.95M |
| Depreciation & Amortization | ¥149K | ¥135K | ¥112K |
| Stock-Based Compensation | ¥16.42M | -- | -- |
| Change in Receivables | -¥10.10M | ¥20.31M | -¥1.27M |
| Change in Inventory | -¥998K | ¥3.03M | -¥5.00M |
| Change in Payables | ¥19.49M | -¥16.25M | -¥1.63M |
| **Operating Cash Flow** | -¥148.5M | -¥16.13M | -¥45.80M |
| Capital Expenditure | -¥1.01M | -¥38K | -¥112K |
| **Free Cash Flow** | -¥149.5M | -¥16.17M | -¥45.91M |
| **Investing Cash Flow** | -¥1.61M | -¥33K | -¥112K |
| **Financing Cash Flow** | ¥153.9M | ¥17.02M | ¥50.07M |
| **Net Change in Cash** | ¥1.93M | ¥847K | ¥4.16M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Gross Margin** | 13.1% | 13.9% | 12.7% |
| **Operating Margin** | -29.7% | -7.5% | -7.3% |
| **Net Profit Margin** | -53.2% | -41.9% | -47.7% |
| Return on Assets (ROA) | -197.6% | -310.1% | -- |
| Current Ratio | 0.48x | 0.21x | -- |
| Quick Ratio | 0.44x | 0.16x | -- |
| **Revenue Growth (YoY)** | +16.7% | +12.4% | -- |
| Gross Profit Growth (YoY) | +9.6% | +23.2% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
